Lux Capital

Lux Capital, established in 2000, is a New York-based venture capital firm managing over $4 billion in assets. It invests in early-stage and growth companies at the intersection of technology and sciences, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. Lux actively supports entrepreneurs, having helped build over 20 companies from scratch, and employs a strategy that enhances portfolio companies' connectivity, insights, and industry leadership.

Peter Hebert

Managing Partner

Lan Jiang

Investor

Alex Nguyen

Partner

Segolene Scarborough

CFO

Tess Van Stekelenburg

Partner

Shaquille Vayda

Principal

Shaq Vayda

Principal

David Yang

Principal

Past deals in Early Venture Stage

Jericho Security

Series A in 2025
Jericho Security is a cybersecurity company specializing in protecting businesses from generative AI-based threats. It has developed a proprietary generative AI platform, cyberGPT, which simulates realistic cyberattacks, creates new defense strategies, and provides personalized training to enhance cybersecurity efficiency and prevent potential losses.

ConductorAI

Series A in 2025
ConductorAI specializes in AI-driven compliance solutions for government agencies. Its platform attributes work to relevant policies and procedures, connects model outputs with primary source materials, and surfaces existing policies within workflows, helping agencies navigate complex processes and ensure compliance.

Tldraw

Series A in 2025
Tldraw is a startup founded in 2021 by Steve Ruiz, offering a collaborative drawing application accessible without any login requirement. The platform provides an infinite canvas where users can draw lines or objects, add text, and insert media such as images, videos, or GIFs. Tldraw's software is designed to facilitate software development by offering a virtual whiteboard with hand-drawn style diagrams. It also provides developer tools for integrating its canvas into other platforms. The service is available free of charge.

Kela Technologies

Series A in 2025
Kela Technologies specializes in providing a secure, open platform that facilitates the swift and seamless integration of commercial and military systems, catering to the needs of Western defense. This platform offers battle-tested technology, interoperability, and adaptability, empowering defense organizations to tackle contemporary warfare challenges and keep pace with emerging innovations.

Atrandi Biosciences

Series A in 2025
Atrandi Biosciences is a privately held biotechnology company that focuses on next-generation single-cell technology, specifically single-cell eukaryotic DNA sequencing. By leveraging proprietary microfluidics technology, Atrandi develops hardware systems, consumables, and software services designed to create user-friendly workflows. This innovative approach facilitates the analysis of genomic alterations and cellular heterogeneity, enabling researchers to effectively study complex biological systems at the single-cell and single-molecule levels.

Physical Intelligence

Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

11x

Series A in 2024
11x is a technology company that specializes in developing autonomous digital workers aimed at optimizing organizational processes, particularly in go-to-market operations. By automating specific roles, 11x enables businesses to streamline their hiring budgets and enhance productivity. The company's primary offerings include Alice, an AI-powered sales development representative, and Jordan, both of which are part of its platform that provides customizable artificial intelligence workers. These digital workers are designed to perform tasks traditionally handled by knowledge workers, allowing organizations to improve efficiency and scale effectively as they grow.

Maven AGI

Series A in 2024
Maven AGI is a technology company specializing in modern artificial intelligence solutions. It focuses on revolutionizing customer support experiences by employing AI to reduce costs, enhance speed and quality, and boost operational efficiency. The company's AI solutions empower teams to increase productivity and focus on tasks that require human expertise. Additionally, Maven AGI offers services such as customer acquisition strategy and operational planning. With a team of 50 employees across various roles, the company aims to transform customer support through AI-driven insights and automation.

Privateer

Series A in 2024
Privateer is a company focused on developing data infrastructure to support the sustainable growth of the new space economy. It utilizes proprietary knowledge graph technology to enhance the collection and processing of information about space objects. As orbital environments become increasingly congested, this technology facilitates safe and effective maneuvering for space operators, contributing to the overall safety and accessibility of space for all.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is a biotechnology company based in the San Francisco Bay Area that focuses on leveraging artificial intelligence to enhance drug discovery and development. The company integrates machine learning research, extensive biological and clinical data generation, and therapeutic product development to innovate how diseases are treated. By employing advanced AI methodologies, Xaira aims to transform the traditional drug development process, enabling the creation of more effective therapies. Through its multidisciplinary approach, the company seeks to advance understanding of biology and improve the overall efficiency of developing new treatments.

Summer Health

Series A in 2024
Summer Health is a provider of pediatric telehealth services designed to simplify access to healthcare for families. The company enables timely communication with board-certified pediatricians through a text-based platform, allowing users to receive expert answers and reliable advice quickly. Summer Health's services include health tracking and personalized healthcare plans, ensuring that patients can obtain necessary care within minutes. By leveraging digital technology, Summer Health aims to enhance the healthcare experience for families navigating health concerns.

Nominal

Series A in 2024
Nominal specializes in providing a robust engineering data infrastructure platform tailored for hardware engineers. The company focuses on bridging the gap between machines and human experts by ingesting, analyzing, and visualizing mission-critical hardware data from various sources. This enables engineers to gain valuable insights, make reliable decisions, and streamline their workflows efficiently. Nominal's solutions are designed to enhance the reliability and speed of validating critical systems, making it an essential tool for modern hardware teams.

Formic

Venture Round in 2024
Formic is a rapidly growing startup that focuses on simplifying the deployment of robotic automation in industries facing labor shortages, such as food and beverage, advanced manufacturing, and consumer packaged goods. The company develops customized robots designed to enhance operational efficiency and productivity for manufacturers. By offering flexible automation solutions, Formic allows clients to pay for productivity based on their usage, minimizing financial risk associated with traditional automation investments. Through a combination of technology, financing, and operational support, Formic aims to provide manufacturers with easy access to scalable automation solutions, ultimately increasing their output and capacity in a competitive market.

Together AI

Series A in 2024
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.

Armada

Series A in 2023
Armada is a technology company that specializes in edge computing platforms. Its core business involves developing robust, secure, and scalable infrastructure alongside compatible software components. This enables real-time data processing and decision-making for both individuals and businesses at the edge of networks. The company's mission is to bridge the digital divide by providing efficient management and optimization of data through a single control plane.

Modal Labs

Series A in 2023
Modal Labs is a technology company that specializes in machine learning software designed to facilitate code execution in the cloud. Its platform allows users to deploy machine learning models, run massively parallel compute jobs, manage task queues, and host web applications. By utilizing containers, Modal's software automates the provisioning of compute instances, hardware accelerators, and cloud storage. This enables data science teams to concentrate on developing their models and applications without the burden of managing intricate infrastructure, thereby enhancing efficiency and performance in cloud-based computing environments.

Kinetic Automation

Series A in 2023
Kinetic Automation is a forward-thinking company focused on transforming the automotive repair industry by developing a modern infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company operates automotive service centers designed specifically for electric and autonomous vehicles, offering advanced mobility services powered by machine learning and proprietary technology. Kinetic's precision systems enable rapid, accurate, and reliable maintenance and servicing, positioning the company as a key player in providing infrastructure-as-a-service for the future of mobility. By leveraging automation and AI, Kinetic is dedicated to enhancing the efficiency and effectiveness of vehicle maintenance, catering to the evolving needs of electric vehicle owners.

Mendaera

Series A in 2023
Mendaera is a medtech startup dedicated to advancing healthcare technologies, particularly through the development of surgical robots and diagnostic tools. The company aims to digitize clinical judgment and technical expertise, ensuring that high-quality care is accessible to all patients in various care settings. Mendaera's platform, currently under development, integrates robotics, artificial intelligence, real-time imaging, and connectivity to facilitate precise and consistent point-of-care interventions. By aiding physicians in image acquisition and interpretation, Mendaera seeks to eliminate barriers in the patient journey, accelerate recovery, and reduce healthcare costs, thereby enhancing the capabilities of healthcare professionals in performing medical procedures effectively.

Impulse Space

Series A in 2023
Impulse Space is an in-space transportation company founded by Tom Mueller, specializing in providing access beyond Low Earth Orbit (LEO) through a fleet of innovative transportation vehicles. The company’s flight-proven Mira vehicle employs a non-toxic, high-impulse chemical propulsion system, facilitating services such as orbital transport, constellation deployment, and precision reentry from LEO to Geostationary Orbit (GEO). Additionally, the high-energy Helios vehicle, powered by the Deneb engine, enables deliveries to a range of orbits including Medium Earth Orbit (MEO), GEO, heliocentric, lunar, and other planetary destinations. Impulse Space is committed to offering economical and efficient in-space transportation solutions, leveraging a team with a history of delivering reliable rockets to ensure rapid and dependable service for its customers.

Aera Therapeutics

Series A in 2023
Aera Therapeutics is a biotechnology company focused on advancing genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins derived from retroelements, which self-assemble into capsid-like structures capable of packaging and transferring nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to enhance the efficacy and reach of genetic therapies across various tissues and disease areas. Additionally, the company holds a licensed technology that features a therapeutic enzyme platform based on novel, compact, and programmable gene-editing enzymes, further expanding its capabilities in the field of genetic medicine.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Osmo

Venture Round in 2023
Osmo is a company that develops an artificial intelligence platform designed to give computers a sense of smell. By combining advanced AI with olfactory science, Osmo addresses significant challenges in the fragrance industry while also aiming to enhance human health and well-being. The company creates aroma molecules for a variety of products, including perfumes, shampoos, lotions, and candles. Additionally, Osmo's technology has the potential to detect diseases earlier and track pandemics, thereby improving consumer experience and overall wellness. Through its innovative approach, Osmo seeks to transform the way scent is integrated into everyday life and contribute positively to public health.

Cajal Neuroscience

Series A in 2022
Cajal Neuroscience is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. It employs a combination of human genetics, functional genomics, and advanced microscopy techniques to identify novel targets and therapeutics. The company utilizes viral tools and platforms for screening targets that influence the progression of neurodegenerative conditions, alongside functional genetic screening and multi-omics methods. By integrating these state-of-the-art approaches, Cajal Neuroscience aims to advance precision medicine, ultimately enabling healthcare professionals to improve treatment outcomes for patients suffering from neurodegenerative disorders.

Impulse

Series A in 2022
Impulse is a manufacturer of innovative electric home appliances aimed at transforming the home appliance sector by reducing reliance on natural gas and minimizing carbon emissions. The company focuses on integrating battery technology into its products, allowing for energy storage without the need for extensive upgrades to electrical panels. Their flagship product is a high-performance induction stove equipped with a built-in battery, which enables users to electrify their homes with minimal rewiring. This approach not only enhances appliance performance but also facilitates the addition of energy storage to the grid, promoting a healthier and more sustainable living environment for both residential and commercial users.

Column

Series A in 2022
Column is a public benefit company focused on enhancing the value of public information systems through technology. It offers a user-friendly public notice software platform designed to streamline operations for various clients, including governments, legal services, individuals, and businesses, who are mandated by law to publish notices. The company's platform simplifies the publication process and provides an application programming interface that grants read access to the public information ecosystem. This approach aims to make public information more accessible to the general public, thereby improving transparency and efficiency in the dissemination of essential notices.

Epsilon3

Series A in 2022
Epsilon3 develops advanced software technology aimed at modernizing spacecraft operations and complex engineering tasks. The company focuses on creating an industry-standard operational software platform that enhances efficiency and user experience throughout the entire lifecycle of space missions. Its solutions provide interactive, real-time synchronized procedures, detailed analytics, and comprehensive reporting tools, catering to the needs of satellite operators, space manufacturers, and integrators. By improving operational processes, Epsilon3 enables its users to save time and reduce costs, ultimately driving greater productivity in space missions and engineering activities.

Anagenex

Series A in 2022
Anagenex is a seed stage biotechnology company that specializes in drug discovery, focusing on challenging medical targets. The company has developed an innovative platform that significantly accelerates the discovery of small molecule drugs and the identification of pharmaceutical compounds. By utilizing machine learning in conjunction with DNA-encoded libraries, Anagenex's technology can rapidly analyze a vast number of compounds, generating extensive data sets and conducting parallel biochemical experiments. This capability is enhanced by proprietary artificial intelligence models, which facilitate the development of new therapeutic drugs aimed at addressing critical medical needs.

Fruitful

Series A in 2022
Fruitful is a financial wellness platform focused on empowering individuals to manage their finances more effectively. It offers personalized financial advice from qualified specialists and hands-on investment management. The platform simplifies the banking experience by integrating commonly used third-party apps, bank accounts, and financial services into a single dashboard. This subscription-based model equips users with banking tools that enhance financial understanding and promote a secure financial future. Additionally, Fruitful provides access to ultra-high-yield savings, further supporting its members in taking greater control over their money.

LatchBio

Series A in 2022
LatchBio is a biotechnology company founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman. It focuses on developing a data infrastructure aimed at supporting the open-source biocomputing revolution. The company provides a bioinformatics platform specifically designed for cell and gene therapy startups, offering a modern cloud computing stack that enables biotech labs to manage and execute custom workflows, pipelines, and machine learning models. This platform allows scientists to create bioinformatic queries efficiently, without requiring command-line expertise or the burdens of complex system setups. By streamlining data integration and computational processes, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.

Umba

Series A in 2022
Umba is a digital banking company based in Nairobi, Kenya, founded in 2017. It offers a mobile application that provides a range of financial services, including free bank accounts and the ability to apply for, receive, and repay microloans directly through mobile devices. The platform employs machine learning to assess credit eligibility and create risk scores, which helps optimize risk management for users and financial institutions. By delivering an interconnected ecosystem of financial services, Umba empowers customers in Kenya and Nigeria to gain complete control over their finances in a single app.

Hadrian

Series A in 2022
Hadrian is a startup focused on manufacturing precision components specifically for the aerospace and defense industries. The company designs and operates autonomous, software-defined factories that produce critical components for technology firms involved in building rockets, satellites, jets, and electric vertical takeoff and landing (eVTOL) vehicles. By leveraging advanced manufacturing techniques, Hadrian aims to deliver precision components efficiently and cost-effectively, enabling frontier technology enterprises to accelerate their production processes.

Cloaked

Series A in 2022
Cloaked is a privacy-focused company that empowers individuals to manage their personal data through the creation of unlimited, unique identities. Its platform is designed to enhance online and travel experiences by allowing users to access various services without disclosing sensitive information such as personal emails, phone numbers, or addresses. By providing tools that grant users active control over their digital interactions, Cloaked alleviates the pressure to share personal information both online and in person, thereby prioritizing consumer privacy in a digital landscape.

Alife

Series A in 2022
Alife is a San Francisco-based company founded in 2020 by Paxton Maeder-York that focuses on developing artificial intelligence tools to enhance the success rates of pregnancy for individuals undergoing fertility treatments. The company aims to assist physicians by utilizing deep learning and advanced software technologies to aid in the selection of the healthiest embryos during in vitro fertilization (IVF). By connecting fertility specialists with patients, Alife strives to improve the overall chances of a healthy pregnancy and ultimately support the mission of helping people have healthy children.

Creyon Bio

Series A in 2022
Creyon Bio is a pre-clinical stage company focused on advancing drug development through a data-driven methodology. It specializes in engineering RNA-based medicines and their components by creating proprietary datasets that inform advanced machine learning models. This innovative approach enables the rapid identification of design rules and engineering principles necessary for the development of safe and effective oligonucleotide-based medicines. By leveraging these insights, Creyon Bio aims to improve the efficiency of the drug development process, ultimately contributing to cost savings in the healthcare sector while catering to diverse patient populations.

Neo.Tax

Series A in 2022
Neo.Tax is a California-based company that specializes in tax preparation and filing services through its innovative tax automation software. The firm focuses on simplifying the complex processes associated with tax credits, particularly the Research and Development (R&D) tax credit, which can potentially return significant funds to companies. In response to recent changes in tax legislation regarding R&D capitalization, Neo.Tax has developed a unique product aimed at helping businesses navigate these new regulations and optimize their tax liabilities. The platform leverages machine learning algorithms to efficiently gather and organize data from various sources, including emails, documents, and financial systems. This automation not only enhances accuracy but also streamlines the audit readiness of finance teams across a range of organizations, from early-stage startups to established public companies.

Parallel Markets

Series A in 2022
Parallel Markets Inc. is a New York-based company founded in 2018 that specializes in identity verification and accreditation for financial platforms. The company operates an online platform that simplifies the onboarding and verification process for both investors and investment platforms. It enables investors to authenticate and share their credentials across various platforms with a single click, streamlining the way individuals and entities assert their qualifications. Parallel Markets provides a comprehensive suite of identity products, facilitating efficient investor verification and allowing for easier engagement in the investment process. By focusing on user-friendly solutions, the company aims to enhance the overall experience of onboarding for its partners and their clients.

Gandeeva Therapeutics

Series A in 2022
Gandeeva Therapeutics is a precision biotechnology company focused on developing innovative therapeutics by leveraging cryogenic electron microscopy and machine learning to target and modulate key protein-protein interactions. The company employs a comprehensive structure-guided drug discovery platform that includes target prediction and validation, hit identification from virtual and fragment libraries, and lead optimization. Gandeeva's preclinical oncology pipeline is designed to address challenging cancers through the creation of novel protein interaction modulators, specifically interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area, Canada, Gandeeva Therapeutics aims to enhance treatment options and reduce the risks of late-stage clinical failures in oncology.

Formic

Series A in 2022
Formic is a rapidly growing startup that focuses on simplifying the deployment of robotic automation in industries facing labor shortages, such as food and beverage, advanced manufacturing, and consumer packaged goods. The company develops customized robots designed to enhance operational efficiency and productivity for manufacturers. By offering flexible automation solutions, Formic allows clients to pay for productivity based on their usage, minimizing financial risk associated with traditional automation investments. Through a combination of technology, financing, and operational support, Formic aims to provide manufacturers with easy access to scalable automation solutions, ultimately increasing their output and capacity in a competitive market.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on advancing female reproductive health through innovative therapies. Recognizing the significant lack of treatment options in this underserved area, Gameto employs cutting-edge scientific techniques to develop solutions that enhance the quality of life for women. The company utilizes cellular engineering to create a platform that produces engineered ovarian and endometrial cell lines capable of mimicking the functions of natural cells, including hormone production and response. This platform underpins a portfolio of cellular therapeutics aimed at addressing various female reproductive diseases. Gameto's first initiative, Fertilo, targets improvements in in vitro fertilization (IVF) and egg freezing processes, striving to make them shorter, safer, and more effective. Additionally, the company is developing Deovo, an organoid model of the female reproductive system, and Ameno, a cell-based therapy designed to mitigate health issues related to primary ovarian insufficiency and menopause. Through these efforts, Gameto aims to transform the landscape of female reproductive health care.

Waymark

Series A in 2022
Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.

PERCHWELL

Series A in 2021
Perchwell is a data and workflow platform tailored for the residential real estate industry. It provides tools that facilitate real-time market analysis and insights, allowing brokers to access and manage listing data effectively. The platform also supports features such as scheduled home viewings and client collaboration, which empower real estate professionals to make informed decisions and deliver timely advice to their clients. By integrating these functionalities, Perchwell enhances the efficiency and effectiveness of real estate transactions.

Nomic

Series A in 2021
Nomic is a bioengineering company focused on enhancing access to the human proteome, similar to the accessibility of the human genome. The company is developing the next-generation ELISA platform, known as nELISA, which is designed for high-throughput protein measurement. Nomic's solutions enable scientists to conduct protein profiling efficiently, allowing them to determine the scope and scale of their experiments. The platform features a cost-effective reagent system that integrates seamlessly with existing industry cytometers, facilitating high-throughput analysis and the creation of custom protein panels. By leveraging advanced technology, Nomic aims to empower researchers and nanotechnology developers to utilize DNA as a flexible and programmable linker, effectively addressing challenges such as cross-reactivity in protein measurements.

Shiru

Series A in 2021
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. It specializes in the development and production of proteins aimed at replacing dairy products and eggs within the food industry. Utilizing artificial intelligence, bioinformatics, and precision biology, Shiru focuses on the discovery and creation of novel, sustainable protein ingredients. By leveraging computational design, the company aims to provide enhanced protein solutions that support environmentally friendly practices while meeting consumer demands. Shiru's innovative approach positions it at the forefront of efforts to create sustainable and healthier food options.

Copia Automation

Series A in 2021
Copia Automation is a technology company that specializes in providing modern developer tools tailored for industrial automation engineers. Their primary product offers Git-based source control for Programmable Logic Controller (PLC) programming, enhancing version control, change visibility, and collaboration. This streamlines machinery commissioning and operation, leading to faster delivery times and maximized uptime for clients across various industries.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures is a Brooklyn-based company established in 2019 that specializes in developing and producing microbial cultures for the food industry. The company focuses on reassembling nature's microbes into innovative combinations, allowing food manufacturers to create new varieties of food with enhanced benefits. Their product line includes Koji, a traditional Japanese ingredient used in miso, sake, and soy sauce, as well as microbial cultures for fermented sodas, beers, and plant-based dairy alternatives. Kingdom Supercultures employs an automated scientific platform that features a comprehensive biobank of Generally Recognized As Safe (GRAS) microbial strains and utilizes advanced algorithms to predict and assemble microbial communities. By providing functional ingredients and biopreservatives, the company aims to support healthy and sustainable food development across various industries, including food, beverage, personal care, and beauty.

A-Alpha Bio

Series A in 2021
A-Alpha Bio, Inc. is a biotechnology company specializing in synthetic biology and advanced quantitative measurement of protein interactions to facilitate drug development. Founded in 2017 and headquartered in Seattle, Washington, the company offers its proprietary AlphaSeq platform, which enables high-throughput mapping of protein-protein interactions. This technology allows for the simultaneous identification and quantification of interactions among thousands of protein pairs, streamlining the drug discovery process by aiding in the identification of potential drug targets and enhancing the understanding of disease mechanisms. By providing biologics and molecular glue discovery and optimization services, A-Alpha Bio supports pharmaceutical companies in optimizing binding and specificity to multiple target proteins. The team comprises synthetic biologists, structural biologists, and next-generation sequencing experts dedicated to overcoming challenges in the drug development process.

Atavistik Bio

Series A in 2021
Atavistik Bio is a pre-clinical biotechnology company dedicated to discovering and developing novel therapies for metabolic diseases and cancer. The company specializes in identifying metabolite-protein interactions and leveraging nature's allosteric control mechanisms to create innovative drug candidates. By focusing on genetically validated targets, Atavistik Bio aims to pioneer first-in-class treatments that harness these unique biological processes, positioning itself at the forefront of biopharmaceutical advancements.

Ahana

Series A in 2021
Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions using PrestoDB. The company aims to make interactive analytics more accessible by simplifying the process for organizations of various sizes. Ahana also works to promote growth within the Presto community, building on its widespread use at large internet companies like Facebook, Uber, and Twitter.

HiHello

Series A in 2021
HiHello, Inc. is a software company based in Palo Alto, California, founded in 2018. It specializes in developing a contact management solution that enables users to share their contact details efficiently. The application allows individuals to distribute their information to clients and friends through various methods, including codes, text messages, and emails. HiHello's platform includes features such as personalized digital business cards, the ability to scan paper cards, and a dynamic address book that ensures users maintain an up-to-date network. By facilitating connections, HiHello aims to enhance business relationships and support users in nurturing their professional networks.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Enveda Biosciences

Series A in 2021
Enveda Biosciences is a biotechnology company that employs artificial intelligence-powered tools to investigate and define molecules sourced from living organisms. Its primary objective is to build an exhaustive database of chemical biodiversity, thereby expediting the discovery of novel medicines. The company's innovative drug discovery platform integrates machine learning, metabolomics, and robotics to analyze natural samples for both chemical structure and biological activity, eliminating the need for isolating individual compounds or extensive experimentation. This enables healthcare industry clients to develop a wide range of new medications, from antibiotics to hypotensives.

System

Series A in 2021
System Inc. is a Public Benefit Corporation that specializes in developing software to enhance the understanding and management of complex systems. The company creates value-driven technology that organizes knowledge and data from disparate sources, enabling users to uncover statistical relationships and insights. By integrating seamlessly with various components of the data and information ecosystem, System's software empowers professionals and organizations to visualize, relate, and address challenges effectively. Through its innovative approach, System Inc. aims to facilitate better decision-making and problem-solving in a variety of contexts.

Dyno Therapeutics

Series A in 2021
Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing adeno-associated virus (AAV) vectors for gene therapy applications. Its innovative platform utilizes artificial intelligence, next-generation DNA synthesis, and high-throughput sequencing to design and optimize AAV capsids, which are crucial for delivering therapeutic genes effectively and safely. By leveraging machine learning and quantitative experimentation, Dyno Therapeutics aims to revolutionize the design of gene vectors, focusing on enhancing cell-targeting capabilities. The company's approach seeks to advance the field of gene therapy, making it possible for researchers to access novel AAV vectors that can facilitate more efficient in vivo delivery of new treatments.

Eikon Therapeutics

Series A in 2021
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Established in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By directly measuring the interactions of chemical compounds with individual proteins within a live cellular environment, Eikon Therapeutics enhances the understanding of biological processes and supports the development of targeted therapies. The integration of biology, engineering, and chemistry in its proprietary platforms allows Eikon Therapeutics to streamline the drug discovery process, advance clinical programs, and expand its pipeline of potential medications.

Pawp

Series A in 2021
Pawp, Inc. is a digital health clinic and telehealth platform founded in 2020 and based in New York, New York. The company focuses on providing pet owners with 24/7 access to licensed veterinary professionals, enabling them to manage their pets' health effectively. Pawp's services aim to reduce unnecessary veterinary visits by offering expert consultations online, thereby lowering costs for pet owners. Additionally, the company provides a pet emergency fund of $3,000 per year, acting as a financial safety net for unforeseen veterinary expenses. By combining access to veterinary care and emergency funding, Pawp empowers pet owners to make informed health decisions for their pets.

Higharc

Series A in 2021
Higharc, Inc. is a technology company based in Durham, North Carolina, founded in 2018. It offers a comprehensive web platform designed for homebuilders and new homebuyers, focusing on three-dimensional home design and customization. The platform allows users to create tailored home designs while managing plans, standards, and options within a single interface. It provides accurate materials lists and generates permit-ready construction documents, streamlining the building process. By enabling builders to design and sell homes in 3D, Higharc aims to enhance the efficiency of design, construction, and sales, ultimately reducing material waste and costly errors. The company's mission is to support builders in creating high-quality homes and communities in a more affordable manner.

Buf

Series A in 2021
Buf Technologies, Inc. is a technology company based in Buffalo, New York, established in 2020. The company specializes in providing tools for managing Protocol Buffers APIs, facilitating streamlined API development and lifecycle management. Its offerings include a linter that enforces best practices in API design, a breaking change detector that ensures compatibility at both the source code and wire levels, and a configurable file builder for generating images. By simplifying the process of creating and distributing consistent APIs, Buf enables teams to easily lint and monitor their schema evolutions, thereby safeguarding user experience and compliance with design standards. This technology allows organizations to manage diverse protocols effectively while focusing on their core competencies without the need for reinventing serialization methods for structured data.

Multiply Labs

Series A in 2021
Multiply Labs is a pioneer in the field of personalized pharmaceuticals, specializing in the manufacturing of tailor-made capsules that cater to the unique needs of individual patients. By integrating advanced robotics technology with pharmaceutical science, the company has developed a unique robotic manufacturing facility capable of producing these customized capsules efficiently and cost-effectively. Multiply Labs stands out as the first company to introduce 3D printed capsules to the market, positioning itself at the forefront of innovation in individualized drug delivery. This approach allows for the creation of capsules that align with the specific metabolic requirements of patients, ultimately enhancing the effectiveness of pharmaceutical treatments.

ZEDEDA

Series A in 2021
ZEDEDA, Inc. is a developer of cloud-native edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks at the enterprise edge. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, India, the company offers solutions such as Edge Quick Connect for Azure IoT Edge. This software-as-a-service enables customers to manage and secure their IoT deployments through virtualization and facilitates the use of cloud-managed gateways for remote administration. ZEDEDA's platform supports a variety of applications, including predictive analytics in renewable energy and industrial automation, allowing organizations to monitor and manage real-time edge applications while avoiding vendor lock-in.

Plexium

Series A in 2021
Plexium, Inc. is a biotechnology company based in San Diego, California, specializing in the development of targeted protein degradation therapeutics aimed at treating cancer and neurodegenerative diseases. Founded in 2017, Plexium focuses on identifying E3 ligase modulating small molecules to create innovative therapies. The company has developed a screening platform known as DELPhe, which utilizes advanced techniques to miniaturize cell-based assays for high-content readouts. This platform enables the modulation of E3 ligases to selectively target various cancers, including small cell lung and breast tumors, while also inducing immune responses. By exploring next-generation drug candidates that extend beyond traditional approaches, Plexium is poised to uncover new therapeutic possibilities across a wide range of medical applications.

Vosbor

Series A in 2021
Vosbor is a global digital marketplace specializing in the trade of bulk agricultural commodities, including corn, wheat, soybeans, and palm oil, among others. Established in 2019 and headquartered in Amsterdam with additional offices in Singapore, Vosbor facilitates international trade logistics and settlement through its advanced trading platform, which is built on blockchain technology. This innovative approach allows for secure data reconciliation and the sharing of documents through smart contracts, ensuring transparency and efficiency in the trading process. By connecting buyers and sellers, Vosbor aims to streamline the execution of trade, finance, and shipping within the agricultural sector.

Runway

Series A in 2020
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.

LabGenius

Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Auransa

Series A in 2020
Auransa Inc. is a clinical stage drug development company founded in 2014 and based in Palo Alto, California. The company focuses on inventing novel drugs for challenging diseases, including cancer, autoimmune disorders, and neurological conditions, utilizing its proprietary AI-driven drug discovery platform. This platform enables Auransa to analyze extensive genomics data from human disease tissues, facilitating the study of molecular disease subtypes and the prediction of effective compounds and targets for specific patient populations. Auransa's current pipeline includes a first-in-class investigational new drug for cancer that is undergoing clinical trials. Additionally, the company collaborates with various partners in the biopharma industry to enhance its research and development efforts.

Statespace

Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Mos

Series A in 2020
Mos is a financial services platform focused on supporting students in navigating the complexities of financial aid and college funding. The company provides a suite of financial solutions, including checking accounts and debit cards, specifically tailored for students. Its platform is designed to simplify the financial aid process, offering comprehensive guidance and research to help students identify scholarships and financial resources. By addressing financial barriers, Mos aims to enhance access to educational opportunities and empower students in their financial journeys.

Braid Health

Series A in 2020
Braid Health, Inc. is a digital health innovation company founded in 2018 and based in San Francisco, California. It specializes in developing artificial intelligence-driven diagnostic tools specifically for radiology. By creating an AI-powered diagnostic collaboration platform, Braid Health enhances the speed, quality, and workflow of radiologists and healthcare providers. The company’s systems integrate AI diagnostics with the expertise of board-certified radiologists, facilitating real-time quality assurance and seamless Electronic Health Records (EHR) integration. This approach enables healthcare professionals to deliver accurate diagnoses efficiently, ultimately improving the quality of patient care.

Tecton

Series A in 2020
Tecton is a technology company that specializes in providing an enterprise-level feature store platform for machine learning (ML). Its core offering enables ML teams to efficiently build, serve, and scale features from diverse data sources, aiming to enhance model performance and drive tangible business outcomes. The platform addresses the unique data challenges faced by ML teams, making it accessible to a broader range of companies.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a company focused on developing digital treatments for individuals with chronic health conditions, particularly gastrointestinal diseases. Its flagship offering, Parallel, is a clinically validated, minimal-contact digital program specifically designed for patients suffering from irritable bowel syndrome (IBS). The program aims to deliver both physical and psychological support to enhance patient well-being. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also maintains an office in London, United Kingdom. The company was previously known as Mahana Health, Inc. before rebranding in July 2019.

AllStripes

Series A in 2020
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.

Looking Glass

Series A in 2020
Looking Glass Factory, established in 2015, specializes in developing and manufacturing holographic displays. Based in Brooklyn, New York, with a subsidiary in Hong Kong, the company offers the Looking Glass, a desktop holographic display that combines light field and volumetric display technologies. This enables users, such as 3D creators, artists, and designers, to make, share, and interact with 3D content without the need for VR or AR headsets. Additionally, the company provides volumetric printing services and software for managing holographic displays. Its solutions cater to various industries, including drug discovery, medical visualization, experiential marketing, and 3D storytelling.

Avail Medsystems

Series A in 2020
Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Rivet

Series A in 2020
Rivet Health, Inc. is a company specializing in healthcare revenue cycle management through its software-as-a-service platform. Founded in 2018 and based in Cottonwood Heights, Utah, Rivet provides tools that enhance financial transparency and operational efficiency for healthcare providers and patients. Its offerings include features that allow providers to quote and collect patient costs upfront and manage payer contracts effectively. The software also helps patients understand their financial responsibilities, detect underpayments, and create accurate estimates, thereby fostering better communication between providers and payers. By addressing the complexities of healthcare transactions, Rivet aims to improve the overall experience for both patients and providers.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

SkySelect

Series A in 2020
SkySelect is a digital procurement platform that specializes in the aircraft parts industry, which is valued at $100 billion. The company provides technology and services designed to streamline the purchasing process for airlines, allowing maintenance leaders to automate the procurement and fulfillment of high-quality aircraft parts. By leveraging a wide network of leading suppliers, SkySelect's platform facilitates efficient sourcing, manages quote workflows, and tracks the delivery of spare parts. This automation enhances the purchasing experience, enabling airlines to engage effectively with vendors and ensure timely operations.

Lumafield

Series A in 2020
Lumafield is a company that specializes in industrial computed tomography (CT) solutions aimed at non-destructive testing and inspection for engineers. Its flagship product, the Neptune X-ray CT scanner, offers detailed imaging capabilities that allow engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which provides cloud-based, AI-powered analysis, facilitating automated inspections and collaborative tools for engineers. Additionally, Lumafield's Triton system is engineered for high-speed scanning, catering to high-volume manufacturing processes. The company’s solutions are utilized across multiple industries, including aerospace, automotive, electronics, and medical devices, ultimately enhancing product quality and reliability throughout the development process.

Hugging Face

Series A in 2019
Hugging Face, established in 2016 and based in New York, specializes in open-source machine learning technologies. It operates a platform that facilitates collaboration on machine learning projects, including models, datasets, and applications. The company aims to democratize machine learning by providing tools and services that support and advance the field, while also offering paid computing and enterprise systems to accelerate development.

Chronosphere

Series A in 2019
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Fiddler AI

Venture Round in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.

LabGenius

Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Variant Bio

Series A in 2019
Variant Bio Inc. is a biotechnology company focused on developing therapeutics through the exploration of human genetic diversity. Founded in 2018 and headquartered in Seattle, Washington, the company seeks to identify individuals and populations exhibiting extreme outlier traits relevant to various medical conditions. By employing advanced sequencing technologies, statistical genetics, and machine learning, Variant Bio analyzes the genetic underpinnings of these traits to uncover new therapeutic targets. The company's mission is to enhance global health by addressing unmet medical needs, particularly in areas such as neurodegenerative, autoimmune, and cardiometabolic diseases.

Fiddler AI

Series A in 2019
Fiddler Labs, Inc. is a company that specializes in developing an artificial intelligence platform designed to help businesses analyze, manage, and deploy their machine learning models effectively. Founded in 2018 and headquartered in Palo Alto, California, Fiddler offers an Explainable AI Engine that promotes transparency and understanding in AI solutions. This platform allows users across data science, product, and business teams to comprehend, validate, and manage their AI implementations, ensuring that these systems deliver reliable and trustworthy experiences for end-users. By providing statistical metrics, performance monitoring, and centralized controls, Fiddler aims to make AI more accessible and trustworthy for enterprises, ultimately unlocking the complexities of AI and enhancing user confidence in its applications.

Caper

Series A in 2019
Caper, founded in 2019, specializes in developing AI-powered smart shopping carts designed to revolutionize physical retail. Their technology, inspired by Amazon Go's innovations, integrates image recognition, sensor fusion, and artificial intelligence into a compact, user-friendly cart. Shoppers can simply place their groceries inside the cart for automatic scanning and checkout, eliminating the need for cashiers and enhancing shopping efficiency. Caper aims to rapidly scale its solution across existing grocery stores, aiming to transform traditional retail practices.

OpenSpace

Series A in 2019
OpenSpace is a technology company based in San Francisco, California, founded in 2017. It specializes in automated 360-degree video job site capture and mapping, providing construction professionals with advanced photo documentation software that captures images every half-second and links them to project plans. The company's core offering utilizes artificial intelligence to generate complete, navigable photo representations of construction sites, significantly enhancing data capture speed compared to traditional methods. Additionally, OpenSpace offers the Clear Sight product suite, which incorporates AI-powered analytics to quantify project progress, facilitating better collaboration among builders and minimizing risks associated with text-based workflows.

Yonder

Series A in 2019
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to define the authentic internet category by providing cultural context to information as it circulates online. Yonder believes that adding this context is essential to prevent the dehumanization of information, which can contribute to issues such as fake accounts, misinformation, and disinformation. By striving to enhance the flow of information, Yonder seeks to foster a more trustworthy and open digital environment, countering trends of information gatekeeping and mistrust.

Lightform

Series A in 2019
Lightform, Inc. is a computer vision and hardware company based in San Francisco, California, founded in 2014. The company specializes in developing technology for projected augmented reality, offering sound-reactive projectors, projector kits, and creator products that transform spaces through projection mapping. Lightform's innovative hardware tools and desktop application enable users to create animated content for various scenes, control projectors wirelessly from laptops or phones, and seamlessly integrate real objects with projected light. The company also provides 3D scanning options that allow for the scanning of complex scenes, automatically fine-tuning alignment and enhancing the projection mapping workflow with AI-generated effects and filters.

Veo Robotics

Series A in 2019
Veo Robotics, Inc., founded in 2016 and based in Waltham, Massachusetts, specializes in developing robotics systems designed for industrial automation. The company focuses on creating high-performance industrial robots that can safely and efficiently collaborate with human workers. Their innovative products leverage advanced computer vision, 3D sensing, and artificial intelligence to enhance the flexibility and productivity of manufacturing workcells. By utilizing proprietary algorithms, sensing technologies, and control systems, Veo Robotics enables clients to optimize their operations, ultimately increasing productivity and reducing operating costs in various manufacturing and logistics environments.

ZEDEDA

Series A in 2019
ZEDEDA, Inc. is a developer of cloud-native edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks at the enterprise edge. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, India, the company offers solutions such as Edge Quick Connect for Azure IoT Edge. This software-as-a-service enables customers to manage and secure their IoT deployments through virtualization and facilitates the use of cloud-managed gateways for remote administration. ZEDEDA's platform supports a variety of applications, including predictive analytics in renewable energy and industrial automation, allowing organizations to monitor and manage real-time edge applications while avoiding vendor lock-in.

Workit Health

Series A in 2019
Workit Health, Inc. is a provider of online therapeutic content and counseling services focused on substance use recovery. Founded in 2014 and based in Ann Arbor, Michigan, the company operates an online platform that offers interactive resources, medication-assisted treatment, and psychiatric support through its mobile app. Workit Health delivers harm reduction-based opioid addiction treatment and facilitates access to both virtual and in-person medical and psychosocial support. Serving a diverse clientele that includes employers, educational institutions, healthcare facilities, and recovery communities, Workit Health aims to provide clinically proven telemedicine services that enable individuals to seek help for substance use disorders in a private, flexible manner, ensuring minimal disruption to their daily lives. The company has locations in multiple states, including California, New Jersey, Alaska, and Washington.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is a technology and clinical services organization based in New York, specializing in connecting caregivers to care teams through its innovative health care platform. The company offers 24/7 telehealth support aimed at caregivers and care recipients, particularly focusing on high-need, frail senior populations. Vesta partners with home care agencies, health plans, and healthcare providers to develop value-based population health programs that prioritize clinical quality and improved health outcomes. Founded in 2008 and originally known as Hometeam Technologies, Inc., Vesta Healthcare has established itself as a leader in enhancing caregiver insights and facilitating personalized engagement in the healthcare setting.

Bright Machines

Series A in 2018
Bright Machines, Inc. is a manufacturing company that specializes in robotic arms and cells for micro factories, focusing on the assembly and inspection of products. Founded in 2018 and headquartered in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico, the company combines robotics and advanced software to enhance manufacturing processes. Its software-defined manufacturing platform utilizes artificial intelligence and machine learning to create adaptable, sensor-rich robots with computer vision capabilities. This innovative approach aims to reduce reliance on manual labor and help businesses meet the increasing demands of modern manufacturing, ultimately improving yields while lowering costs.

Aeva

Series A in 2018
Aeva is a machine vision company focused on developing advanced optical-based sensors for the automotive industry, particularly for autonomous vehicles. Established in 2016 and headquartered in Mountain View, California, Aeva specializes in Frequency Modulated Continuous Wave (FMCW) technology, which enables the creation of a 4D LiDAR-on-chip. This innovative technology integrates vision, depth, and motion sensing into a single product, offering superior range and resolution under various weather conditions. Aeva's sensors are designed to measure the velocity of every pixel in a scene, enhancing the perception capabilities of autonomous machines. The company's applications extend beyond automotive uses, with potential in consumer electronics, health, industrial automation, and security, operating primarily in North America, Europe, the Middle East, and Asia.

Applied Intuition

Series A in 2018
Applied Intuition, Inc. is a company that creates software infrastructure to facilitate the safe development, testing, and deployment of autonomous vehicles at scale. Founded in 2017 and headquartered in Sunnyvale, California, the company also maintains offices in Silicon Valley and Detroit, Michigan. Its advanced simulation infrastructure software offers a comprehensive suite of products focused on simulation and analytics, enabling automotive industries to thoroughly test and expedite the development of their autonomous vehicle technologies. By providing sophisticated tools designed for scalability, Applied Intuition supports the automotive sector in navigating the complexities of autonomous vehicle deployment effectively.

Yonder

Series A in 2018
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to define the authentic internet category by providing cultural context to information as it circulates online. Yonder believes that adding this context is essential to prevent the dehumanization of information, which can contribute to issues such as fake accounts, misinformation, and disinformation. By striving to enhance the flow of information, Yonder seeks to foster a more trustworthy and open digital environment, countering trends of information gatekeeping and mistrust.

Oasis Labs

Series A in 2018
Oasis Labs, Inc. is a blockchain technology company founded in 2018 and headquartered in San Francisco, California. It operates a privacy-first cloud computing platform designed for scalable and privacy-preserving smart contracts. The platform enables the development of decentralized applications that prioritize privacy and performance, addressing challenges related to data security and scalability in real-world applications. Oasis Labs offers a suite of tools, including privacy tools, development SDKs, and dashboards, that facilitate the creation and management of smart contracts while ensuring secure data handling across businesses. The company's innovative approach aims to enhance blockchain adoption by overcoming traditional limitations associated with performance and privacy.

Novel Effect

Series A in 2018
Novel Effect is a Seattle-based company specializing in voice-driven media and entertainment. It has developed an interactive storytelling application that utilizes voice recognition technology to synchronize theme music and sound effects with the reading experience. This innovative application provides voice-activated audio enhancements for children's books, allowing sound effects and music to play in real-time as a child reads. By blending the physical and digital worlds, Novel Effect creates immersive and engaging experiences that foster learning and interaction between children and parents, while ensuring that the content remains accessible and non-distracting.

Arraiy

Series A in 2018
Arraiy, Inc. is a technology company based in Palo Alto, California, that specializes in developing a computer vision and machine learning platform tailored for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy aims to transform the filmmaking process by collaborating with major studios and award-winning artists. The company's platform leverages advanced AI techniques to enhance visual storytelling, allowing creators to seamlessly integrate real and virtual worlds. By focusing on machine learning, Arraiy seeks to expand the creative possibilities for filmmakers, thereby unlocking a new era of visual storytelling. As of 2020, Arraiy operates as a subsidiary of Matterport, Inc.

Senti Bio

Series A in 2018
Senti Bio, established in 2016 and headquartered in South San Francisco, specializes in synthetic biotechnology for therapeutic development. The company's core focus is engineering gene circuits, a platform technology that enables precise control over cellular behavior. Senti Bio's innovative approach allows for the creation of therapies with enhanced specificity and control, particularly in oncology. Their product pipeline includes SENTI-202, a targeted cancer therapy using gene-engineered allogeneic CAR-NK cells designed to eliminate cancer cells while sparing healthy bone marrow, and SENTI-301A for treating hepatocellular carcinoma.

Pager

Series A in 2018
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Primer

Series A in 2017
Primer Technologies, Inc., established in 2014 and headquartered in San Francisco, specializes in developing software that leverages machine learning and natural language processing to analyze vast amounts of textual data across multiple languages. Its platform automates the parsing and collation of documents, uncovering insights and generating reports comparable to those produced by human analysts. This enables governments and corporations to better understand and monitor global information, facilitating informed decision-making.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.